Cell Therapy: The Final Frontier for Treatment of Neurological Diseases.

Dutta, Susmita and Singh, Gurbind and Sreejith, Sailaja and Mamidi, Murali Krishna and Husin, Juani Mazmin and Datta, Indrani and Pal , Rajarshi and Das, Anjan Kumar (2013) Cell Therapy: The Final Frontier for Treatment of Neurological Diseases. CNS Neuroscience and Therapeutics, 19 (1). pp. 5-11. ISSN 1755-5930.

[img] PDF
CNS_Neuroscience_&_Therapeutics-Rajarshi_Pal.pdf - Published Version
Restricted to Registered users only

Download (267kB) | Request a copy

Abstract

Neurodegenerative diseases are devastating because they cause increasing loss of cognitive and physical functions and affect an estimated 1 billion individuals worldwide. Unfortunately, no drugs are currently available to halt their progression, except a few that are largely inadequate. This mandates the search of new treatments for these progressively degenerative diseases. Neural stem cells (NSCs) have been successfully isolated, propagated, and characterized from the adult brains of mammals, including humans. The confirmation that neurogenesis occurs in the adult brain via NSCs opens up fresh avenues for treating neurological problems. The proof-of-concept studies demonstrating the neural differentiation capacity of stem cells both in vitro and in vivo have raised widespread enthusiasm toward cell-based interventions. It is anticipated that cell-based neurogenic drugs may reverse or compensate for deficits associated with neurological diseases. The increasing interest of the private sector in using human stem cells in therapeutics is evidenced by launching of several collaborative clinical research activities between Pharma giants and research institutions or small start-up companies. In this review, we discuss the major developments that have taken place in this field to position stem cells as a prospective candi- date drug for the treatment of neurological disorders.

Item Type: Article
Additional Information: Copy right of this article is belongs to John Wiley and Sons.
Uncontrolled Keywords: Cell transplantation and clinical trials;Neural differentiation;Neurorepair;Stem cells.
Subjects: Regenerative Medicine > MIRM Bangalore
Depositing User: MCON Library
Date Deposited: 13 Apr 2013 09:23
Last Modified: 13 Apr 2013 09:23
URI: http://eprints.manipal.edu/id/eprint/79645

Actions (login required)

View Item View Item